Mojca Lunder

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 3

Top Topics

Anti Inflammatory

Combination Therapy

Top Venues

Cardiovascular diabetology

BioMed research international

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Miodrag Janić, Matej Cankar, Jan Šmid, Alenka France Štiglic, Aleš Jerin, Mišo Šabovič, Andrej Janez, Mojca Lunder
Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes. Journal of diabetes research 2022 (2022)
Mojca Lunder, Miodrag Janić, Miha Japelj, Andrej Juretič, Andrej Janež, Mišo Šabovič
Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus. Cardiovascular diabetology 17 (1) (2018)
Miodrag Janić, Mojca Lunder, Mišo Šabovič
A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial age. BioMed research international 2015 (2015)